04/08/2026
MASLD: Magaca Cusub ee Fatty Liver Disease – Fahamka, Baadhitaanka iyo Daaweynta
Hordhac
Cudurka dufanka ku urura beerka waa mid ka mid ah cudurrada beerka ee ugu badan dunida. Muddo dheer waxaa loo yaqaanay Non-Alcoholic Fatty Liver Disease (NAFLD), halka nooca uu la socdo caabuqa iyo dhaawaca unugyada beerka loo yaqaanay Non-Alcoholic Steatohepatitis (NASH).
Bishii Juun 2023, khubaro caalami ah oo ay hoggaaminayeen ururrada AASLD, EASL iyo ALEH ayaa si rasmi ah u beddelay magaca cudurkan. Magaca cusub wuxuu noqday Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), halka NASH loo beddelay Metabolic Dysfunction-Associated Steatohepatitis (MASH).
Isbeddelkan wuxuu ka tarjumayaa fahamka cusub ee muujinaya in cudurkan inta badan uu ka dhasho cilladaha dheef-shiid kiimikaadka (metabolic dysfunction).
Magacyadii H**e iyo Kuwa Cusub
Magacii H**e Magaca Cusub
Non-Alcoholic Fatty Liver Disease (NAFLD) Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Non-Alcoholic Steatohepatitis (NASH) Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Fatty Liver Disease Steatotic Liver Disease (SLD) (magaca guud)
Sababaha Loo Beddelay Magaca
Isbeddelka magaca waxaa loo sameeyay dhowr sababood oo muhiim ah:
• In magaca uu si cad u muujiyo in cudurku xiriir dhow la leeyahay cayilka, sonkorowga nooca 2-aad, insulin resistance iyo dyslipidemia.
• In laga tago ereyga "Non-Alcoholic", maadaama uu qeexayay waxa cudurku uusan ahayn halkii uu ka sharxi lahaa waxa uu yahay.
• In la yareeyo ceebeynta iyo jahawareerka bukaannada.
• In la mideeyo cilmi-baarista iyo hagitaannada caafimaadka ee caalamiga ah.
Waa Maxay MASLD?
MASLD waa cudur lagu garto Astaamo ay kamid yihin
• Dufan ku urura beerka (hepatic steatosis), iyo
• Ugu yaraan hal calaamad oo metabolic dysfunction ah sida:
o Cayil ama miisaan dheeraad ah
o Sonkorowga nooca 2-aad ama prediabetes
o Dhiig-kar
o Triglycerides oo sareeya
o HDL cholesterol oo hooseeya
Nooca uu beerku yeesho caabuq iyo dhaawac unugyada beerka waxaa loo yaqaan MASH, waana heerka ugu halista badan ee u gudbi kara fibrosis, cirrhosis iyo kansarka beerka.
Baadhitaanka (Diagnosis)
Baadhitaanka MASLD wuxuu ku salaysan yahay isku darka Xogta bukaanka, baaritaanka jirka, shaybaadhka iyo sawir-qaadista.
1. Xogta Bukaanka
Dhakhtarku wuxuu qiimeeyaa:
• Cayilka (BMI iyo wareegga dhexda)
• Sonkorowga
• Dhiig-karka
• Heerarka dufanka dhiigga
• Isticmaalka khamriga
• Daawooyinka dhaawici kara beerka
• Xogta qoys
2. Baaritaannada Dhiigga
Waxaa badanaa la sameeyaa:
• ALT
• AST
• ALP
• GGT
• Total iyo Direct Bilirubin
• Albumin
• PT/INR (haddii beerku dhaawac weyn qabo)
Sidoo kale waxaa la qiimeeyaa:
• Fasting Blood Sugar ama HbA1c
• Lipid Profile
• CBC
• Serum Creatinine
Waxaa muhiim ah in sidoo kale laga saaro cudurrada kale ee beerka sida:
• Hepatitis B
• Hepatitis C
• Autoimmune liver disease
• Hemochromatosis
• Wilson disease (bukaannada da'da yar)
• Alpha-1 Antitrypsin deficiency haddii loo baahdo
3. Sawir-qaadista
Waxaa ugu badan:
• Ultrasound – baaritaanka koowaad ee lagu ogaado dufanka beerka.
• Transient Elastography (FibroScan) – wuxuu cabbiraa adkaanta beerka (fibrosis) iyo xaddiga dufanka.
• MRI-PDFF – waa habka ugu saxda badan ee lagu cabbiro dufanka beerka, laakiin looma isticmaalo si joogto ah.
4. Qiimaynta Fibrosis
Hagitaannada AASLD waxay ku talinayaan in marka h**e la isticmaalo:
• FIB-4 Score
Haddii FIB-4 uu sareeyo:
• FibroScan
• ELF Test (meelaha laga heli karo)
5. Liver Biopsy
Liver biopsy looma baahna bukaannada oo dhan.
Waxaa la sameeyaa haddii:
• Ogaanshuhu shaki ku jiro.
• Laga shakiyo MASH.
• Fibrosis heer sare ah laga shakiyo.
• Ama natiijooyinka baaritaannadu is khilaafaan.
Daaweynta (Management)
Ilaa hadda ma jiro hal dawo oo daweyn buuxda u ah MASLD, sidaas darteed daaweyntu waxay diiradda saartaa wax ka beddelka hab-nololeedka iyo xakamaynta cudurrada la socda.
1. Isbeddelka Hab-nololeedka (Daaweynta Ugu Muhiimsan)
Miisaanka oo la dhimo
Yoolka ugu wanaagsan waa:
• 5% miisaanka → dufanka beerka wuu yaraadaa.
• 7–10% → caabuqa beerka (MASH) wuu fiicnaan karaa.
• ≥10% → fibrosis-na wuu hagaagi karaa.
Jimicsi
Waxaa lagu talinayaa:
• Ugu yaraan 150 daqiiqo toddobaadkii oo jimicsi dhexdhexaad ah.
• Jimicsiga xoogga (resistance training) 2–3 jeer usbuucii.
Cuntada
Waxaa lagu talinayaa:
• Mediterranean Diet
• Khudaar iyo miro badan
• Kalluun
• Whole grains
• Olive oil
• Laws
Waxaa la yareeyaa:
• Cabitaannada sonkorta leh
• Macmacaanka
• Rootiga cad
• Hilibka warshadaysan
• Dufanka trans-fat
2. Daaweynta Cudurrada La Socda
Si adag ayaa loo xakameeyaa:
• Sonkorowga
• Dhiig-karka
• Kolestaroolka
• Cayilka
Gunaanad
MASLD waa magaca cusub ee rasmiga ah ee cudurka h**e loogu yiqiin NAFLD. Isbeddelkan wuxuu ka tarjumayaa xaqiiqda ah in cudurku inta badan ka dhasho cilladaha dheef-shiid kiimikaadka. Ogaanshaha wuxuu ku salaysan yahay taariikhda bukaanka, baaritaannada dhiigga, ultrasound, FibroScan iyo qiimaynta fibrosis. Daaweynta ugu waxtarka badan waa dhimista miisaanka, jimicsiga joogtada ah, cunno caafimaad leh iyo xakamaynta sonkorowga, dhiig-karka iyo dufanka dhiigga. Daawooyin cusub sida resmetirom ayaa hadda loo oggolaaday bukaannada qaarkood ee qaba MASH iyo fibrosis.
Tixraacyo
1. Rinella ME, et al. A Multi-Society Delphi Consensus Statement on New Fatty Liver Disease Nomenclature. Journal of Hepatology. 2023.
2. American Association for the Study of Liver Diseases (AASLD). Practice Guidance on the Clinical Assessment and Management of MASLD/MASH (2023–2024).
3. European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on MASLD.
4. U.S. Food and Drug Administration (FDA). Resmetirom (Rezdiffra) Approval for Noncirrhotic MASH with Moderate to Advanced Fibrosis, 2024.